|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:CEO
|
gptkb:Shigeo_Taniuchi
|
|
gptkbp:country
|
gptkb:Japan
|
|
gptkbp:founded
|
1890
|
|
gptkbp:founder
|
gptkb:Kenjiro_Nishida
|
|
gptkbp:headquarters_location
|
gptkb:Osaka,_Japan
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Santen Pharmaceutical
|
|
gptkbp:industry
|
pharmaceuticals
|
|
gptkbp:listedOn
|
gptkb:Nikkei_225
|
|
gptkbp:market
|
gptkb:Asia
gptkb:Europe
gptkb:North_America
|
|
gptkbp:member
|
gptkb:Japan_Pharmaceutical_Manufacturers_Association
|
|
gptkbp:net_sales
|
over 200 billion yen (recent years)
|
|
gptkbp:notableProduct
|
gptkb:Diquas
gptkb:Hyalein
gptkb:Tafluprost
gptkb:Tapros
|
|
gptkbp:numberOfEmployees
|
over 4,000
|
|
gptkbp:products
|
over-the-counter eye care products
prescription ophthalmic drugs
|
|
gptkbp:researchInterest
|
glaucoma
retinal diseases
dry eye
|
|
gptkbp:servesArea
|
worldwide
|
|
gptkbp:specializesIn
|
ophthalmology
|
|
gptkbp:stockExchange
|
gptkb:Tokyo_Stock_Exchange
|
|
gptkbp:stockSymbol
|
4536
|
|
gptkbp:subsidiary
|
gptkb:Santen_Inc._(USA)
gptkb:Santen_Oy_(Finland)
|
|
gptkbp:website
|
https://www.santen.com/
|
|
gptkbp:bfsParent
|
gptkb:Cosopt
gptkb:Trusopt
gptkb:Rescula
|
|
gptkbp:bfsLayer
|
5
|